THANK YOU FOR SUBSCRIBING
The brain-computer interface is one area of NeuroTech that many people are familiar with (BCI). Brain-computer interfaces (BCIs) receive brain signals, interpret them, and convert them into commands that are sent to output devices that carry out the appropriate behavior.
Fremont, CA: Neurotechnologies are developed based on the human nervous system and are modeled after the human brain. Neurotech can aid researchers in their understanding of brain function and dysfunction, as well as doctors in their treatment of neurological disorders. For Longevity, some Neurotech applications are aimed at improving cognitive efficiency, improving sleep, and improving brain health. Over the next decade, advances in AI could transform Neurotech. In terms of technology and as an industry, Neurotech has unrivaled growth opportunities.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Brain-Computer Interface
The brain-computer interface is one area of Neurotech that many people are familiar with (BCI). Brain-computer interfaces (BCIs) receive brain signals, interpret them, and convert them into commands that are sent to output devices that carry out the appropriate behavior. People with neuromuscular disabilities such as amyotrophic lateral sclerosis, cerebral palsy, stroke, or spinal cord injury could benefit from BCI. Humans will be able to have USB ports inserted in their brains as technology progresses, allowing them to upload data. The global BCI market is anticipated to reach $1.8 billion by 2024.
Neuromodulation
Neuromodulation is a form of brain stimulation that involves stimulating particular areas of the brain. Neuromodulatory stimuli come in a variety of forms, each with its own set of characteristics and applications. In the United States, more than 150,000 individuals have surgical brain implants, mostly to treat Parkinson's disease. Neuromodulation therapies are a non-pharmaceutical treatment choice for chronic conditions. Compared to pharmaceuticals, these drugs are more targeted, less costly, and have fewer side effects. A cure for intractable pain that includes stimulating the spinal and peripheral nervous systems in different parts of the brain is one application of this technology. By 2022, the global neuromodulation system market is expected to reach $13.3 billion.
More in News